Rapid Tophus Resolution in Chronic Refractory Gout Patients Treated with Pegloticase

被引：0
|
作者：
Mandell, Brian F. [1 ]
Baraf, Herbert S. B. [2 ]
Yeo, Anthony [3 ]
Lipsky, Peter E. [4 ]
机构：
[1] Cleveland Clin, Rheumatol, Cleveland, OH 44106 USA
[2] Ctr Rheumatol & Bone Res, Wheaton, MD USA
[3] Horizon Pharma, Lake Forest, IL USA
[4] AMPEL BioSolut LLC, Charlottesville, VA USA
来源：
ARTHRITIS & RHEUMATOLOGY | 2017年 / 69卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2054
引用
收藏
页数：3
相关论文
共 50 条
  • [1] RAPID TOPHUS RESOLUTION IN CHRONIC REFRACTORY GOUT PATIENTS TREATED WITH PEGLOTICASE
    Mandell, B.
    Yeo, A.
    Lipsky, P.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 365 - 365
  • [2] Influence of Renal Function on the Velocity of Tophus Resolution and Achievement of Disease Remission in Patients with Chronic Refractory Gout Treated with Pegloticase
    Mandell, Brian F.
    Schlesinger, Naomi
    Edwards, N. Lawrence
    Yeo, Anthony
    Lipsky, Peter E.
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [3] Tophus resolution in patients with chronic refractory gout who have persistent urate-lowering responses to pegloticase
    Mandell, Brian F.
    Yeo, Anthony E.
    Lipsky, Peter E.
    ARTHRITIS RESEARCH & THERAPY, 2018, 20
  • [4] Tophus resolution in patients with chronic refractory gout who have persistent urate-lowering responses to pegloticase
    Brian F. Mandell
    Anthony E. Yeo
    Peter E. Lipsky
    Arthritis Research & Therapy, 20
  • [5] Complete Tophus Response in Patients with Chronic Gout Initiating Pegloticase Treatment
    Becker, Michael A.
    Gonter, Neil J.
    Pope, Janet E.
    Malamet, Raymond L.
    Baraf, Herbert S. B.
    ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S812 - S812
  • [6] Target Tophus Size and Complete Response Rates In Patients Treated With Open-Label Pegloticase For Chronic Gout Refractory To Conventional Therapy
    Keenan, Robert T.
    Dalbeth, Nicola
    Baraf, Herbert S. B.
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S505 - S505
  • [7] PEGLOTICASE FOR TREATING REFRACTORY CHRONIC GOUT
    George, R. L., Jr.
    Sundy, J. S.
    DRUGS OF TODAY, 2012, 48 (07) : 441 - 449
  • [8] Pegloticase immunogenicity: the relationship between efficacy and antibody development in patients treated for refractory chronic gout
    Lipsky, Peter E.
    Calabrese, Leonard H.
    Kavanaugh, Arthur
    Sundy, John S.
    Wright, David
    Wolfson, Marsha
    Becker, Michael A.
    ARTHRITIS RESEARCH & THERAPY, 2014, 16 (02)
  • [9] Pegloticase immunogenicity: the relationship between efficacy and antibody development in patients treated for refractory chronic gout
    Peter E Lipsky
    Leonard H Calabrese
    Arthur Kavanaugh
    John S Sundy
    David Wright
    Marsha Wolfson
    Michael A Becker
    Arthritis Research & Therapy, 16
  • [10] Pegloticase In Treatment-Refractory Chronic Gout
    Lyseng-Williamson, Katherine A.
    DRUGS, 2011, 71 (16) : 2179 - 2192
12345